These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 32487639

  • 41. Salvage radiotherapy for locoregionally recurrent extrahepatic bile duct cancer after radical surgery.
    Kim E, Kim YJ, Kim K, Song C, Kim JS, Oh DY, Nam EM, Chie EK.
    Br J Radiol; 2017 Dec; 90(1080):20170308. PubMed ID: 28937265
    [Abstract] [Full Text] [Related]

  • 42. Role of radiotherapy, in particular intraluminal brachytherapy, in the treatment of proximal bile duct carcinoma.
    González González D, Gouma DJ, Rauws EA, van Gulik TM, Bosma A, Koedooder C.
    Ann Oncol; 1999 Dec; 10 Suppl 4():215-20. PubMed ID: 10436826
    [Abstract] [Full Text] [Related]

  • 43. Adjuvant radio-chemotherapy for extrahepatic biliary tract cancers.
    Bonet Beltrán M, Roth AD, Mentha G, Allal AS.
    BMC Cancer; 2011 Jun 24; 11():267. PubMed ID: 21702920
    [Abstract] [Full Text] [Related]

  • 44. External radiation therapy and transcatheter iridium in the treatment of extrahepatic bile duct carcinoma.
    Foo ML, Gunderson LL, Bender CE, Buskirk SJ.
    Int J Radiat Oncol Biol Phys; 1997 Nov 01; 39(4):929-35. PubMed ID: 9369143
    [Abstract] [Full Text] [Related]

  • 45. External beam radiotherapy versus brachytherapy in the management of malignant oesophageal dysphagia: a retrospective study.
    Eldeeb H, Reza S, Shmueli U, Logsdail G, Hinks P, Mukherjee S.
    J BUON; 2012 Nov 01; 17(3):508-11. PubMed ID: 23033290
    [Abstract] [Full Text] [Related]

  • 46. Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study.
    Ibrahim SM, Mulcahy MF, Lewandowski RJ, Sato KT, Ryu RK, Masterson EJ, Newman SB, Benson A, Omary RA, Salem R.
    Cancer; 2008 Oct 15; 113(8):2119-28. PubMed ID: 18759346
    [Abstract] [Full Text] [Related]

  • 47. Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer.
    Ma KW, Cheung TT, She WH, Chok KSH, Chan ACY, Dai WC, Chiu WH, Lo CM.
    World J Surg; 2018 Mar 15; 42(3):823-834. PubMed ID: 28905105
    [Abstract] [Full Text] [Related]

  • 48. Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma.
    McMasters KM, Tuttle TM, Leach SD, Rich T, Cleary KR, Evans DB, Curley SA.
    Am J Surg; 1997 Dec 15; 174(6):605-8; discussion 608-9. PubMed ID: 9409582
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Biliary drainage, photodynamic therapy and chemotherapy for unresectable cholangiocarcinoma with jaundice.
    Fuks D, Bartoli E, Delcenserie R, Yzet T, Celice P, Sabbagh C, Chatelain D, Joly JP, Cheron N, Dupas JL, Regimbeau JM.
    J Gastroenterol Hepatol; 2009 Nov 15; 24(11):1745-52. PubMed ID: 19780885
    [Abstract] [Full Text] [Related]

  • 52. Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma.
    Gerhards MF, van Gulik TM, González González D, Rauws EA, Gouma DJ.
    World J Surg; 2003 Feb 15; 27(2):173-9. PubMed ID: 12616432
    [Abstract] [Full Text] [Related]

  • 53. Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging.
    Kim JY, Kim MH, Lee TY, Hwang CY, Kim JS, Yun SC, Lee SS, Seo DW, Lee SK.
    Am J Gastroenterol; 2008 May 15; 103(5):1145-51. PubMed ID: 18177454
    [Abstract] [Full Text] [Related]

  • 54. Magnitude of combination therapy of radical resection and external beam radiotherapy for patients with carcinomas of the extrahepatic bile duct and gallbladder.
    Itoh H, Nishijima K, Kurosaka Y, Takegawa S, Kiriyama M, Dohba S, Kojima Y, Saitoh Y.
    Dig Dis Sci; 2005 Dec 15; 50(12):2231-42. PubMed ID: 16416167
    [Abstract] [Full Text] [Related]

  • 55. Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients.
    Zeng ZC, Tang ZY, Fan J, Zhou J, Qin LX, Ye SL, Sun HC, Wang BL, Li D, Wang JH, Zeng MS, Guo W, Tan YS.
    Cancer J; 2006 Dec 15; 12(2):113-22. PubMed ID: 16630402
    [Abstract] [Full Text] [Related]

  • 56. Biliary tree malignancies.
    Erickson BA, Nag S.
    J Surg Oncol; 1998 Mar 15; 67(3):203-10. PubMed ID: 9530894
    [Abstract] [Full Text] [Related]

  • 57. Cholangiocarcinoma: CT-guided High-Dose Rate Brachytherapy (CT-HDRBT) for Limited (<4 cm) and Large (>4 cm) Tumors.
    Jonczyk M, Collettini F, Schnapauff D, Geisel D, Böning G, Feldhaus F, Denecke T, Wieners G, Hamm B, Gebauer B.
    Anticancer Res; 2018 Oct 15; 38(10):5843-5852. PubMed ID: 30275209
    [Abstract] [Full Text] [Related]

  • 58. Combined brachytherapy and external beam radiation: an effective approach for palliation in esophageal cancer.
    Laskar SG, Lewis S, Agarwal JP, Mishra S, Mehta S, Patil P.
    J Contemp Brachytherapy; 2015 Dec 15; 7(6):453-61. PubMed ID: 26816502
    [Abstract] [Full Text] [Related]

  • 59. Role of intraluminal brachytherapy as a palliative treatment modality in unresectable cholangiocarcinomas.
    Chigurupalli K, Vashistha A.
    J Cancer Res Ther; 2021 Dec 15; 17(1):10-12. PubMed ID: 33723125
    [Abstract] [Full Text] [Related]

  • 60. Brachytherapy in the treatment of cholangiocarcinoma.
    Shinohara ET, Guo M, Mitra N, Metz JM.
    Int J Radiat Oncol Biol Phys; 2010 Nov 01; 78(3):722-8. PubMed ID: 20207503
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.